Search

Your search keyword '"Allez, Matthieu"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Allez, Matthieu" Remove constraint Author: "Allez, Matthieu" Database OpenAIRE Remove constraint Database: OpenAIRE
31 results on '"Allez, Matthieu"'

Search Results

1. Prevalence and determinants of fatigue in patients with IBD: a cross-sectional survey from the GETAID

2. Role of adherent and invasive E. coli in Crohn's Disease: Lessons from the postoperative recurrence model

3. Impact of the Ileal Microbiota on Surgical Site Infections in Crohn's Disease: A Nationwide Prospective Cohort

4. A clinical decision support tool may help to optimise vedolizumab therapy in Crohn’s disease

5. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment

6. The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease

7. Determinants of IBD-related disability: a cross-sectional survey from the GETAID

8. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

9. Integrated microbiota and metabolite profiles link Crohn’s disease to sulfur metabolism

10. Ustekinumab for Perianal Crohn's Disease

12. Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID

14. Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation

15. Additional file 1: of Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment

16. Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease

17. Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained Remission

18. Predictors of immunogenicity to anti-TNF therapy in IBD: results of the ABIRISK study

19. Postoperative Complications after Ileocecal Resection in Crohn’s Disease: A Prospective Study From the REMIND Group

20. Diffusion-weighted MRI in Crohn's disease: Current status and recommendations

21. Predictors of post-operative endoscopic recurrence in Crohn's disease: a prospective study of the REMIND group

22. Definitions of the endoscopic lesions in Crohn's disease: reproductibility study and GETAID expert consensus

23. Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients with Inflammatory Bowel Disease

24. P-097 Novel Anti-NKG2D Monoclonal Antibody (NNC0142-0002) in Crohnʼs Disease

25. Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy

26. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection

27. Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II

28. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet

29. P-101 Anti-MAdCAM Antibody PF-00547659 in Crohnʼs Disease

30. Efficacy of a second course of azathioprine in patients with Crohn's disease relapsing after azathioprine withdrawal

31. The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies

Catalog

Books, media, physical & digital resources